Amdocs (NASDAQ:DOX) Director Eliahu Meir Gelman Buys 2,500 Shares of Company Stock

Amdocs Limited (NASDAQ:DOX – Get Free Report) Director Eliahu Meir Gelman bought 2,500 shares of Amdocs stock in a transaction that occurred on Monday, November 9th. The shares were acquired at an average price of $41.72 per share, for a total transaction of $104,300.00. Following the acquisition, the director directly owned 353,446 shares in the company, valued at approximately $14,745,767.12. This represents a 0.71% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Amdocs Stock Down 2.6%

Shares of Amdocs stock opened at $43.64 on Tuesday. The company has a fifty day moving average price of $57.14 and a 200 day moving average price of $60.79. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23. Amdocs Limited has a twelve month low of $39.96 and a twelve month high of $84.95. The stock has a market cap of $4.71 billion, a price-to-earnings ratio of 6.65, a price-to-earnings-growth ratio of 1.44 and a beta of 0.42.

Amdocs (NASDAQ:DOX – Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The technology company reported $1.98 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.98. Amdocs had a return on equity of 20.81% and a net margin of 10.59%. The firm had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.19 billion. During the same period in the prior year, the firm earned $1.83 EPS. The firm’s quarterly revenue was up 3.8% compared to the same quarter last year. Equities research analysts forecast that Amdocs Limited will post 5.82 earnings per share for the current fiscal year.

Amdocs Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 31st will be given a dividend of $0.5690 per share. The ex-dividend date of this dividend is Thursday, December 31st. This represents a $2.28 annualized dividend and a yield of 5.2%. Amdocs’s payout ratio is 48.82%.

Institutional Trading of Amdocs

A number of hedge funds and other institutional investors have recently modified their holdings of DOX. Pzena Investment Management LLC boosted its holdings in Amdocs by 3.4% in the third quarter. Pzena Investment Management LLC now owns 14,454,911 shares of the technology company’s stock valued at $826,532,000 after purchasing an additional 469,581 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Amdocs by 19.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,463,797 shares of the technology company’s stock valued at $226,045,000 after purchasing an additional 571,036 shares in the last quarter. First Trust Advisors LP grew its stake in Amdocs by 18.7% during the 3rd quarter. First Trust Advisors LP now owns 1,637,842 shares of the technology company’s stock valued at $93,652,000 after purchasing an additional 258,098 shares in the last quarter. Bank of America Corp DE increased its holdings in Amdocs by 29.1% during the 1st quarter. Bank of America Corp DE now owns 1,262,263 shares of the technology company’s stock worth $82,375,000 after purchasing an additional 284,435 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its holdings in Amdocs by 11.2% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,112,976 shares of the technology company’s stock worth $63,703,000 after purchasing an additional 111,800 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have issued reports on DOX. Weiss Ratings raised shares of Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 23rd. Oppenheimer cut shares of Amdocs from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 4th. Stifel Nicolaus reduced their target price on shares of Amdocs from $71.00 to $46.00 and set a “buy” rating on the stock in a research report on Wednesday, November 4th. Zacks Research downgraded shares of Amdocs from a “hold” rating to a “strong sell” rating in a research note on Monday, November 9th. Finally, Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 7th. Two investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $69.00.

Read Our Latest Research Report on DOX

Amdocs Company Profile

(Get Free Report)

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.

Featured Articles

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.